Article
Indications of next-generation sequencing in non-Hodgkin's lymphoma.
Current opinion in oncology - 1 Sept 2020
Heimann Pierre, Dewispelaere Laurent
Abstract excerpt
PURPOSE OF REVIEW: In this study, we will give an overview on the current and foreseeable indications of next-generation sequencing (NGS)-based technologies for the diagnosis, prognostic assessment and decision of individualized treatment strategy in lymphomas. RECENT FINDINGS: Recent NGS-based studies have offered a comprehensive knowledge of the genetic landscapes featuring B-cell and T-cell lymphomas, with...
Topics
- Biomarkers, Tumor
- High-Throughput Nucleotide Sequencing
- Humans
- Liquid Biopsy
- Lymphoma, Non-Hodgkin
- Molecular Targeted Therapy
- Mutation
- Precision Medicine
- Sequence Analysis, DNA
